Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Skin & Soft Tissues Diseases specialty page provides skin & soft tissue-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

SKIN & SOFT TISSUE DISEASES NEWS - Page 1

Measles Infection Causes
Measles infection leaves patients vulnerable to a wide range of other pathogens by destroying antibodies for months or even years, according to a new study.
Single Dose Oritavancin May Lower 30-Day SSTI Hospital Admission Rates
Treating patients who have skin and soft tissue infections with a single dose of oritavancin may lower hospital admission rates compared to vancomycin, at a similar cost.
Enterovirus Antibodies Found in Spinal Fluid of Dozens of AFM Patients
New research found enterovirus antibodies in dozens of patients diagnosed with AFM and ruled out other viruses, offering more insight into the cause of the mysterious polio-like illness.
Contact Precautions in Long-Term VA Facilities Don't Cut MRSA Infections, Study Shows
Although use of gowns and gloves in targeted settings may still be helpful in preventing health care-associated infections, contact precaution policies in VA long-term care facilities had no impact on MRSA acquisition.
 
United States Maintains Measles Elimination Status Despite Record Year
The announcement came just 1 day after health officials in New York State declared the end of the Rockland County measles outbreak.
Examining the 2018-19 New York State Measles Outbreaks
Two late breaker abstracts at IDWeek 2019 provide an in-depth analysis of the 2018-19 measles outbreaks in the state of New York.
No New Measles Cases Documented Last Week in United States
According to the CDC, there were no new cases of measles reported during the week of September 6-12, 2019.
OASIS Pooled Results: Omadacycline Safe and Efficacious in IVDU and non-IVDU
Investigators have presented the microbiological, efficacy, and safety results in the pooled intravenous drug use vs non-intravenous drug use patients in 2 phase 3 ABSSSI studies, OASIS-1 and 2.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?